جست‌وجوی استاد و پژوهشگر

Francis G. Spinaleمشاهده پروفایل

استاد

• Cardiovascular Remodeling
• Heart Failure
• Translational Cardiovascular Research
• +۳ مورد دیگر

Francis G. Spinale is a Professor in the Department of Cell Biology & Anatomy at the University of South Carolina School of Medicine, with concurrent appointments at the Medical University of South Carolina (MUSC) in Surgery, Physiology, Anesthesiology, and Pediatrics since 1996. He serves as Director of the Cardiovascular Translational Research Center and practices as a physician at the WJB Dorn VA Medical Center. His academic credentials include: Ph.D. in Pathology from the Medical University of South Carolina (1985) M.D. from the Medical University of South Carolina (1993) Dr. Spinale's research fundamentally centers on cardiovascular remodeling mechanisms in heart failure, with particular emphasis on matrix metalloproteinases and their tissue inhibitors. His work bridges molecular biology, translational engineering, and clinical applications, pioneering biomaterial-based interventions like biocomposite injections and bioresponsive hydrogels to modulate post-infarction remodeling and cardiac function. This interdisciplinary approach integrates cardiovascular physiology with biomedical engineering to develop novel therapeutic strategies. Analysis of his 2014 publications reveals a cohesive research trajectory targeting extracellular matrix dynamics in heart disease, with consistent focus on left ventricular remodeling after myocardial infarction and pressure overload. His studies strategically combine molecular manipulation of matrix metalloproteinases with advanced biomaterial delivery systems, establishing a translational pipeline from bench to bedside for heart failure therapeutics. His scientific recognition includes: Breakthrough Leadership in Research Award from the University of South Carolina (2014) Fellowship in the American Heart Association Fellowship in the American College of Cardiology Dr. Spinale has secured significant research funding including an NIH Small Business Technology Transfer grant for cardiac microdialysis/microfluidics systems, holds multiple patents, and maintains over 400 peer-reviewed publications. He serves on seven editorial boards and consults for pharmaceutical/biotechnology firms while mentoring researchers through his extensive publication record and leadership roles. He directs the Cardiovascular Translational Research Center, driving collaborations between the School of Medicine and VA systems to advance cardiac research through integrated basic science and clinical investigations.

Michelle Tallquistمشاهده پروفایل

استاد

• Developmental Biology
• Cardiovascular Biology
• Cell Physiology
• +۵ مورد دیگر

Michelle Tallquist is a Professor of Medicine and Director of the Cell & Molecular Biology Graduate Program at the John A. Burns School of Medicine, University of Hawaii. Her research focuses on cardiac and pulmonary microenvironments, particularly the roles of fibroblasts and extracellular matrix (ECM) in development, repair, and disease. She leads the Tallquist Lab, which investigates how fibroblast signaling pathways impact heart and lung function, with emphasis on ECM production, inflammation, and tissue regeneration. Her work has revealed critical insights into cardiac fibroblast lineage specification via Tcf21 transcription factor and PDGFRα signaling. Notable contributions include redefining the identity and heterogeneity of cardiac fibroblasts, their role in myocardial repair, and their implications in conditions like atherosclerosis and bronchopulmonary dysplasia. She also explores fibroblast survival mechanisms and their interactions with cardiomyocytes and inflammatory cells post-injury. Her research employs interdisciplinary approaches, including genetic mouse models, lineage tracing, and single-cell analysis, to bridge basic science and translational medicine. Key collaborations have linked Tcf21 variants to coronary artery disease and identified novel therapeutic targets for fibrotic disorders. Dr. Tallquist’s lab is affiliated with the Center for Cardiovascular Research, fostering interdisciplinary collaborations. Her work emphasizes translating findings from fibroblast biology to improve treatments for heart and lung diseases, with recent studies exploring fibrosis modulation and regenerative strategies.

Jhih-Rong Linمشاهده پروفایل

عضو هیئت علمی

• Genetics
• Genomics
• Aging and Longevity
• +۳ مورد دیگر

Jhih-Rong Lin is a Research Assistant Professor in the Department of Genetics at Albert Einstein College of Medicine. His research focuses on understanding the genetic and genomic mechanisms underlying complex human diseases, particularly neurodegenerative disorders, longevity, and developmental syndromes. He employs computational and systems biology approaches to analyze genomic data, identify disease risk genes, and model genetic pathways. Key research themes include: Genetic variants associated with aging and neurodegeneration (e.g., Alzheimer’s disease, schizophrenia) Post-GWAS analysis for disease gene prioritization (e.g., using tools like PGA) Evolutionary genomics of longevity (e.g., studies on beaver genomes) Epigenetic regulation in cancer progression and development Lin’s work bridges computational methods with experimental validation, contributing to drug discovery for aging-related conditions and improving understanding of genetic modifiers in syndromic disorders. His recent publications highlight discoveries in rare variant analysis, polygenic risk prediction, and systems-level aging mechanisms.

• Exercise physiology
• Skeletal muscle biology and physiology
• Sports nutrition
• +۵ مورد دیگر

Martin Gibala is a Professor in the Department of Kinesiology at McMaster University, where he leads research examining the effects of exercise at molecular to whole-body levels in both healthy individuals and those with chronic diseases. His work spans basic mechanistic studies on skeletal muscle energy metabolism to applied research on physical training and nutrition for health and performance optimization. Dr. Gibala earned his Bachelor of Human Kinetics from the University of Windsor, followed by an M.Sc. from McMaster University and a Ph.D. from the University of Guelph. He completed a postdoctoral fellowship at the Copenhagen Muscle Research Centre, establishing the foundation for his expertise in exercise physiology. His primary research focuses on high-intensity interval training (HIIT) and time-efficient exercise protocols, demonstrating that brief, intense exercise can produce comparable health benefits to traditional longer-duration workouts. His laboratory investigates skeletal muscle metabolism, exercise adaptations, and practical applications of time-efficient training for diverse populations. Dr. Gibala has made significant contributions to understanding how short bursts of vigorous activity ("exercise snacks") can improve cardiometabolic health, glycemic control, and overall fitness with minimal time commitment. Analysis of Dr. Gibala's recent publications reveals an evolving research trajectory with increasing emphasis on technology-enabled exercise interventions, sex-specific responses to training, and practical implementation of time-efficient protocols in real-world settings. His work bridges basic exercise science with public health applications, particularly focusing on making exercise more accessible through time-efficient approaches. Dr. Gibala is also recognized for science communication, having co-authored the popular science book "The One-Minute Workout: Science Shows a Way to Get Fit That's Smarter, Faster, Shorter" (Penguin Random House, 2017). His research has been widely covered in media outlets and has influenced public understanding of time-efficient exercise approaches. As an educator, Dr. Gibala teaches courses including Cardiorespiratory and Metabolic Exercise Physiology, Exercise Metabolism, and Integrative Exercise Physiology. His laboratory at McMaster University conducts both basic and applied research on exercise physiology, with particular focus on skeletal muscle metabolism, high-intensity interval training, and practical applications of time-efficient exercise protocols for improving health and performance in various populations.

Xingen Leiمشاهده پروفایل

استاد

• Molecular Nutrition
• Animal Science
• Nutritional Genomics
• +۱۰ مورد دیگر

Xingen Lei is Professor of Molecular Nutrition in the Department of Animal Science and Division of Nutritional Sciences at Cornell University's College of Agriculture and Life Sciences (CALS), where he also serves as Associate Dean for the Office of Research and Innovation. He joined Cornell as an assistant professor in 1995, was promoted to associate professor in 2000, full professor in 2006, and associate dean in 2023. His research spans nutritional genomics, sustainable animal agriculture, and human health, with particular expertise in selenium metabolism, phytase development, and alternative protein sources. Lei pioneered the development of bacterial phytases now used in approximately 50 countries, which have reduced global phosphorus excretion from food animals by 30-50%. His work on converting poultry feathers and microalgal biomass into high-value feed proteins addresses critical challenges in global food security. Lei's publication portfolio includes 264 papers with an h-index of 74 and over 19,000 citations. His recent work focuses on selenium's role in diabetes and obesity, protein engineering of hydrolytic enzymes, development of alternative feed proteins, and biofortification of staple foods. His research employs diverse models including food-producing animals, laboratory species, and cellular systems to advance understanding of nutrient metabolism and develop practical applications for improving human health and environmental sustainability. 2025 CALS Outstanding Accomplishments in Research Award 2024 Editor-in-Chief, The Journal of Nutrition, ASN 2021 Fellow of National Academy of Inventors, USA 2017 FASS-AFIA New Frontiers in Animal Nutrition Award 2017 Gary L. Cromwell Award in Mineral Research Professor Lei has advised 145 graduate students, postdocs and visiting fellows while securing substantial grant support from federal and private sponsors. He currently leads a $10 million USDA/NIFA/SAS-funded project to empower the US broiler industry for sustainability and profit. His laboratory hosts 5-8 undergraduate researchers each semester, providing hands-on research experience in molecular nutrition and animal science.

Stephen C. Cannonمشاهده پروفایل

استاد

• Ion Channelopathies
• Muscle Physiology
• Neurology
• +۳ مورد دیگر

Stephen C. Cannon, MD, PhD, is a Professor in the Department of Physiology at the David Geffen School of Medicine at UCLA. He holds academic appointments in Physiology and Molecular and Medical Pharmacology. His primary research focuses on ion channelopathies of skeletal muscle, investigating how ion channel mutations cause diseases such as periodic paralysis and myotonia. He has held leadership roles, including Chair of Physiology at UCLA and Associate Dean at UT Southwestern Medical Center. Education: B.S. and M.S. in Mechanical Engineering (Washington University, 1980), Medical Scientist Training Program at Johns Hopkins (MD and PhD). Residency at Massachusetts General Hospital and postdoctoral training with David Corey. Faculty positions at Harvard Medical School, UT Southwestern, and UCLA since 2015. Research Interests: Molecular mechanisms of ion channel mutations in muscle diseases, computational modeling of muscle excitability, and pre-clinical therapeutic strategies. Key discoveries include sodium channel defects in periodic paralysis and gating pore currents in calcium channels. Current projects explore exercise-induced triggers for periodic paralysis attacks. Awards: Over 20 awards, including the Biophysical Society Award (2022), MERIT Award (NIH, 2009), and multiple endowed chairs in neurology and neuromuscular disease. Lab: The Cannon Lab at UCLA focuses on ion channel dysfunction and develops mouse models to study disease mechanisms. Collaborations include translational research on drug repurposing for periodic paralysis treatment.

• Health Services Research
• Psycho-Oncology
• Cancer Care
• +۳ مورد دیگر

Dr. Kirsty Galpin holds the dual role of Research Associate and Research Manager at the Psycho-Oncology Co-operative Research Group (PoCoG) within the School of Psychology at the University of Sydney. She also previously contributed to the Sydney Catalyst Flagship Program 'EnRICH,' focusing on lung cancer care quality improvement. Her career began as a registered nurse in the UK, followed by a PhD in Nursing from the University of Edinburgh, where she studied intensive care nurses' sedation decision-making practices. Education: PhD in Nursing (University of Edinburgh), professional nursing qualifications. Research Interests: Translational health services research with a focus on improving clinical outcomes and quality of life for cancer patients. Her work emphasizes psycho-oncology, supportive care, and evidence-based quality improvement interventions. She has contributed to projects addressing clinical variations in lung cancer treatment and developing tools like the modified Duke Activity Status Index (M-DASI) for preoperative risk assessment. Publications: Over 15 peer-reviewed articles spanning lung cancer care quality metrics, surgical outcomes, intensive care sedation practices, and functional capacity assessment in non-cardiac surgery. Key work includes quality improvement programs in emergency abdominal surgery and perioperative care. Affiliations: PoCoG, Sydney Health Partners, Implementation Science Community of Practice, Cancer Trials Network. No current teaching or student supervision commitments. Grants & Projects: Leadership in multi-center psycho-oncology research, development of clinical quality indicators for lung cancer, and collaborations in global surgery research through initiatives like the METS study. Labs/Teams: Core member of PoCoG's research coordination unit and EnRICH program, contributing to large-scale supportive care research networks.

• Emergency and Critical Care Medicine
• Veterinary Science
• Biomedical Engineering
• +۴ مورد دیگر

Dr. Samantha Livingstone is a Lecturer in Emergency and Critical Care (Education Focused) at the Sydney School of Veterinary Science, University of Sydney. She holds a BVSc (Hons) from the University of Queensland (2011), MANZCVS in Emergency and Critical Care (2017), and a PhD in critical care research (completed at the University of Queensland with the Critical Care Research Group). Her roles include teaching veterinary emergency and critical care, leading the emergency and critical care area of the teaching hospital, and conducting research in coagulation dysfunction, ECMO, and AI in veterinary education. She is a board member of the Australian New Zealand College of Veterinary Scientists and actively involved in curriculum development and veterinary training. Education: BVSc (Hons), University of Queensland (2011) MNZCVS in Emergency and Critical Care (2017) PhD in Critical Care, University of Queensland (2018–2021) Research Interests: Her work spans coagulation dysfunction in heart disease, AI-driven triage systems, and novel medical devices like improved intravenous catheters. She investigates therapies for acute respiratory distress syndrome (ARDS) subphenotypes and the psychological impact of negative experiences on junior veterinarians. Key projects include: Speckle-tracking echocardiography for cardiac afterload analysis Hypothermic ex vivo perfusion for heart transplants ECMO in severe cardiopulmonary failure AI in veterinary education Publications: Recent studies focus on ECMO efficacy, lung imaging in ARDS, and extended heart transplant preservation. Her work bridges preclinical models (e.g., ovine, porcine) with clinical applications in critical care. Awards: 2020 PhD Scholarship, The Common Good Foundation Teaching & Grants: Teaches VETS6401 Small Animal Clinics A. Current grants include an investigation into coagulation abnormalities in cats and dogs with cardiomyopathies (Sydney School of Veterinary Science Start-up Fund). Associations: Australia New Zealand College of Veterinary Scientists (Emergency & Critical Care Chapter) Thrombosis and Haemostasis Society of Australia and New Zealand International Society on Thrombosis and Hemostasis

• Equine genetics and genomics
• Animal behavior genetics
• Inherited diseases in animals
• +۳ مورد دیگر

Dr. Brandon Velie is a Senior Lecturer at the School of Life and Environmental Sciences, University of Sydney. With a PhD in Veterinary Science (2015) and postdoctoral experience at Swedish University of Agricultural Sciences, he specializes in equine genetics and genomics, focusing on athletic performance, behavior, and inherited diseases. His work aligns with the Sydney Institute of Agriculture and research strengths in Healthy Animals and Precision Health. BSc, MSc: Animal Science & Genetics, North Carolina State University PhD: University of Sydney (Veterinary Science) Postdoc: Swedish University of Agricultural Sciences Research spans both broad and specific areas: Equine genetics : Athletic performance, disease resistance, behavioral traits Genomic medicine : QTL mapping, SNP analysis, inherited disorders Animal technology : Biometric monitoring, performance analytics Recent publications (2024-2021) reveal trends across: Performance genetics : Blood pressure regulation, energy metabolism, gait mechanics Health studies : Osteochondrosis, vitiligo-like disorders, opioid response Technological applications : Wearable sensors, genomic databases Dr. Velie supervises research students including Michelle (Applied Feline Genetics) and collaborates on projects like the Australian Heritage Brumby Initiative . He contributes to international conferences (ISAG, SMBE) and maintains ORCID-linked publications.

Carol Robinsonمشاهده پروفایل

استاد

• Native Mass Spectrometry
• Membrane Protein Structure
• Protein-Lipid Interactions
• +۴ مورد دیگر

Dame Carol Robinson DBE FRS FMedSci FRSC holds the Dr Lee's Professor of Chemistry position at the University of Oxford and serves as Director of the Kavli Institute for Nanoscience Discovery. She is Oxford's first female Professor of Chemistry and previously served as the first female Professor of Chemistry at the University of Cambridge (2001-2009). Her foundational work established native mass spectrometry as a critical technology for studying protein structures, interactions, and dynamics. Her research focuses on native mass spectrometry applications for membrane proteins, particularly examining protein-lipid interactions, antimicrobial resistance mechanisms, and post-translational modifications. Current projects include developing membrane mimetics like lipodisqs for physiological environment recapitulation, ejecting complexes directly from native membranes, and linking metabolites to health disorders through her Nativeomics approach. Her work bridges fundamental structural biology with therapeutic applications through OMass Therapeutics, a spin-out company using native MS for drug development in immunologic and genetic disorders. Her publications reveal strong emphasis on membrane protein complexity, lipid microenvironments, and drug discovery applications. Recent work demonstrates native MS capabilities in capturing physiological lipid interactions, characterizing antibiotic mechanisms, and analyzing orphan GPCR signaling complexes. Award highlights include: Benjamin Franklin Medal in Chemistry (2022) Louis Jeantet Prize for Medicine (2022) Dame Commander of the Order of the British Empire (2013) Foreign Associate of the US National Academy of Sciences (2017) Royal Medal A from the Royal Society Professor Robinson founded OMass Therapeutics (formerly OMass Technologies) in 2016, leveraging native mass spectrometry for drug therapy development. Her career includes an eight-year break for child-rearing before becoming Cambridge's first female Chemistry Professor. She served as President of the UK Royal Society of Chemistry and maintains active collaborations across academic and industrial laboratories. Her research group continues advancing native MS methodologies for structural biology challenges, particularly in membrane protein analysis and therapeutic target identification.

Sevasti Zervouمشاهده پروفایل

مدرس

• Cellular Biochemistry
• Metabolism
• Genetics
• +۵ مورد دیگر

Dr Sevasti Zervou is a Stipendiary Lecturer in Cellular Biochemistry at St Peter’s College, University of Oxford, and Director of Studies for the MSc Precision Cancer Medicine program in the Department of Oncology. She holds a PhD in Molecular Medicine from the University of Warwick (2001) and has over 15 years of research experience in cardiovascular medicine, funded by the British Heart Foundation. Her academic roles include teaching undergraduate biochemistry, leading postgraduate modules in genetics for precision oncology, and mentoring junior researchers. Her research focuses on cellular metabolism, genetic regulation of heart function, and metabolic pathways in cardiovascular diseases, diabetes, and cancer. She has pioneered studies on creatine kinase systems, myocardial energetics, and therapeutic targets for heart failure. Beyond academia, she contributes to science outreach through guest lectures for sixth-form students and mentorship programs. Education: BSc (Hons) in Molecular Medicine (Warwick), PhD (Warwick), FHEA (Fellow of the Higher Education Academy). Research expertise includes molecular cloning, transcriptomics, proteomics, and high-throughput drug screening. She coordinates the MSc Precision Cancer Medicine program, overseeing academic content and teaching delivery. Her work integrates clinical research with educational innovation, emphasizing translational applications of cellular biochemistry. Her research portfolio includes over 30 peer-reviewed publications on topics like cardiac energetics, creatine metabolism, and nanomaterials for cardiovascular therapy. She collaborates with multidisciplinary teams in Oxford and has contributed to understanding metabolic inflexibility in heart disease. Teaching responsibilities span undergraduate tutorials in biochemistry (cell structure, metabolism, data analysis) and postgraduate modules in genetic oncology. She actively participates in academic governance as a Member of Congregation at St Peter’s College.

Samuel J. Mackenzieمشاهده پروفایل

استادیار

• Pediatric Neuromuscular Disorders
• Gene-Based Therapies
• Rare Genetic Diseases
• +۳ مورد دیگر

Samuel J. Mackenzie, M.D., Ph.D., is an Assistant Professor in the Department of Neurology at the University of Rochester School of Medicine and Dentistry (SMD). He holds joint appointments in the Center for Health and Technology, Department of Neuroscience, and Department of Pediatrics. Dr. Mackenzie specializes in pediatric neuromuscular disorders, with expertise in neuromuscular electromyography and nerve conduction studies. His research focuses on translating gene-based therapies for rare diseases such as myotonic dystrophy and TANGO2-deficiency disorder. He actively contributes to clinical trials, including a phase III trial for microdystrophin gene therapy in Duchenne Muscular Dystrophy. Education: Bachelor's degree from Cornell University Master's in Exercise Science from University of Delaware MD and PhD from SUNY Upstate Medical University Pediatric Neurology Residency at University of Michigan Neuromuscular Medicine Fellowship at The Ohio State University Research Interests: Dr. Mackenzie's work integrates clinical care and basic science to advance treatments for neuromuscular disorders. Key areas include RNA-targeted oligonucleotides for myotonic dystrophy, B-vitamin supplementation strategies for TANGO2 deficiency, and genotype-phenotype correlations in rare genetic conditions. His NIH-funded projects explore mechanisms of lipid imbalance in TANGO2-related disorders. Awards & Grants: Recently secured NIH-NINDS funding for RNA-targeted therapies. Sub-investigator on a phase III gene therapy trial. Recognized for clinical excellence with 4.9/5 patient ratings for empathy, communication, and care quality. Labs & Teams: Leads the Neuromuscular Electromyography Lab at UR Medicine. Collaborates across disciplines through the Center for Health and Technology to develop innovative diagnostic tools and care pathways.

Le Zhangمشاهده پروفایل

استادیار

• Medical Image Computing
• Machine Learning
• Generative AI
• +۶ مورد دیگر

Dr. Le Zhang is an Assistant Professor in Machine Learning/AI for Digital Healthcare at the University of Birmingham's School of Engineering, part of the College of Engineering and Physical Sciences. He holds an honorary role as Research Fellow at Queen Mary University of London's William Harvey Research Institute. His work focuses on computational modeling, pattern recognition, and machine learning applied to biomedical imaging and data analysis, particularly in Cardiac MRI, Neuroimaging, and Retinal Image Analysis. Education: PhD in Medical Image Computing (University of Sheffield, 2019), Postdoctoral Researcher at University of Oxford (2022), and Research Fellowships at UCL and Queen Mary University of London. Research Interests: Generative AI for Medical Imaging, Explainable Machine Learning in Cardiovascular Applications, Multimodal Learning for Population Health Studies, and Computational Imaging Methods. His work bridges medical imaging, computer vision, and data science to advance clinical decision-making. Key Projects: Generative AI for Medical Imaging (using GANs/Transformers), Learning from Limited Labeled Data in Segmentation Tasks, and Medical Image Quality Control via AI-driven Imputation. Award: MICCAI Young Scientist Award Nominee (2019) Funding: EPSRC PhD/Summer Studentships, Research Kick Starter Grants Collaborations: University of Oxford, Johns Hopkins, Novo Nordisk, Alibaba, Tencent Teaching: Leads modules on Computing for Engineers and Software/Systems Development at Birmingham.

Dale Cowleyمشاهده پروفایل

دانشیار

• Genome Editing
• CRISPR/Cas9 Technology
• Animal Models of Human Disease
• +۴ مورد دیگر

Dale Cowley, PhD, is an Associate Professor in the Department of Genetics at the University of North Carolina School of Medicine. He directs the Animal Models Core Facility, specializing in genome engineering technologies including CRISPR/Cas9, transgenic animal production, and assisted reproductive techniques. His work focuses on creating genetically tailored mouse and rat models for studying human disease mechanisms, with a particular emphasis on improving efficiency for large gene insertions and 'humanized' models. Dr. Cowley holds a B.S. in Microbiology from Brigham Young University and a Ph.D. in Oncological Sciences from the University of Utah. After postdoctoral training at UNC Lineberger Comprehensive Cancer Center, he worked at GlaxoSmithKline before returning to UNC as a Research Assistant Professor. He co-founded TransViragen, Inc., as Chief Scientific Officer. Research interests include optimizing CRISPR/Cas9 applications across diverse mouse strains (e.g., Collaborative Cross, NOD-Rag1KO-Il2rgKO), molecular biology techniques like BAC recombineering, and cryopreservation of genetic strains. His lab provides full-service genome editing solutions, encompassing guide RNA design, embryo microinjection, and ES cell targeting. Recent publications (2020–2025) highlight contributions to viral pathogenesis models, retinal degeneration studies, and pharmacokinetics research using humanized mice. Collaborations have expanded model applications to fields like oncology, immunology, and cardiovascular development. Dr. Cowley’s work bridges basic research and translational medicine, supporting drug development and disease mechanism investigations.

Panos Deloukasمشاهده پروفایل

استاد

• Cardiovascular Genomics
• Genetic Epidemiology
• Molecular Biology
• +۳ مورد دیگر

Professor Panos Deloukas is the Director of the William Harvey Research Institute and a Professor of Cardiovascular Genomics at Queen Mary University of London, within the Faculty of Medicine and Dentistry. He holds a BSc in Chemistry from the Aristotle University of Thessaloniki, an MSc in Microbiology from Paris 7, and a PhD in Genetics from the Biozentrum University of Basel (1991). His career includes pioneering roles in the Human Genome Project and International HapMap Project, followed by research into genetic basis of common diseases and drug response variability. Research interests focus on molecular mechanisms of coronary artery disease (CAD), lipid metabolism, and epigenetic factors in disease progression. He leads studies on gene-environment interactions using large-scale genomic datasets from UK Biobank and international consortia. Notable contributions include identifying over 70 CAD/MI risk loci and developing biomarkers for cardiovascular risk stratification. Awards: Thomson Reuters Highly Cited Researcher (Molecular Biology & Genetics, 2012–present) Top 200 influential scientists in Molecular Biology & Genetics (2002–2012) Top 1% Highly Cited Researcher (2014–2016) Grants and sponsors include British Heart Foundation (BHF), National Institute for Health Research (NIHR), and Horizon 2020. Collaborations involve global consortia such as CARDIoGRAMplusC4D, Global Lipids Genetics Consortium, and UK Biobank Cardiometabolic Consortium. His research team includes Dr. Stavroula Kanoni, Dr. Andrew Smith, and BHF PhD student Olga Giannakopoulou. Key projects investigate epigenetic biomarkers in blood for MI recurrence prediction and functional genomics of CAD risk variants.